These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38274294)

  • 1. Intracellular and extracellular synergistic therapy for restoring macrophage functions via anti-CD47 antibody-conjugated bifunctional nanoparticles in atherosclerosis.
    Luo Q; Dai L; Li J; Chen H; Hao Y; Li Q; Pan L; Song C; Qian Z; Chen M
    Bioact Mater; 2024 Apr; 34():326-337. PubMed ID: 38274294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
    Mueller PA; Kojima Y; Huynh KT; Maldonado RA; Ye J; Tavori H; Pamir N; Leeper NJ; Fazio S
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e1-e9. PubMed ID: 34758632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of myeloid cell-specific SIRPα, but not CD47, attenuates inflammation and suppresses atherosclerosis.
    Singla B; Lin HP; Ahn W; Xu J; Ma Q; Sghayyer M; Dong K; Cherian-Shaw M; Zhou J; Huo Y; White J; Csányi G
    Cardiovasc Res; 2022 Dec; 118(15):3097-3111. PubMed ID: 34940829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting HDAC6 improves anti-CD47 immunotherapy.
    Gracia-Hernandez M; Yende AS; Gajendran N; Alahmadi Z; Li X; Munoz Z; Tan K; Noonepalle S; Shibata M; Villagra A
    J Exp Clin Cancer Res; 2024 Feb; 43(1):60. PubMed ID: 38414061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect.
    Sha X; Dai Y; Chong L; Wei M; Xing M; Zhang C; Li J
    J Nanobiotechnology; 2022 Dec; 20(1):506. PubMed ID: 36456996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nano-bioconjugate modified with anti-SIRPα antibodies and antisense oligonucleotides of mTOR for anti-atherosclerosis therapy.
    Liu Y; Huang Q; He M; Chen T; Chu X
    Acta Biomater; 2024 Mar; 176():356-366. PubMed ID: 38160854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy.
    Zhang YR; Luo JQ; Zhang JY; Miao WM; Wu JS; Huang H; Tong QS; Shen S; Leong KW; Du JZ; Wang J
    Small; 2020 Nov; 16(46):e2004240. PubMed ID: 33107142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells.
    Bian Z; Shi L; Guo YL; Lv Z; Tang C; Niu S; Tremblay A; Venkataramani M; Culpepper C; Li L; Zhou Z; Mansour A; Zhang Y; Gewirtz A; Kidder K; Zen K; Liu Y
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5434-43. PubMed ID: 27578867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonodynamic Therapy Promotes Efferocytosis via CD47 Down-Regulation in Advanced Atherosclerotic Plaque.
    Cao Y; Yao J; Gao W; Cao Z; Diabakte K; Wang L; Sun X; Tian Y
    Int Heart J; 2022 Jan; 63(1):131-140. PubMed ID: 35034916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-378a Modulates Macrophage Phagocytosis and Differentiation through Targeting CD47-SIRPα Axis in Atherosclerosis.
    Chen W; Li X; Wang J; Song N; Zhu A; Jia L
    Scand J Immunol; 2019 Jul; 90(1):e12766. PubMed ID: 30929259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
    Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
    Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of Pro-resolving and Pro-efferocytic Nanoparticles for Atherosclerosis Therapy.
    Patel Y; Manturthi S; Tiwari S; Gahunia E; Courtemanche A; Gandelman M; Côté M; Gadde S
    ACS Pharmacol Transl Sci; 2024 Oct; 7(10):3086-3095. PubMed ID: 39416959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis.
    Flores AM; Hosseini-Nassab N; Jarr KU; Ye J; Zhu X; Wirka R; Koh AL; Tsantilas P; Wang Y; Nanda V; Kojima Y; Zeng Y; Lotfi M; Sinclair R; Weissman IL; Ingelsson E; Smith BR; Leeper NJ
    Nat Nanotechnol; 2020 Feb; 15(2):154-161. PubMed ID: 31988506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG-Conjugated Silver Nanoparticles as a Multifunctional Nanomedicine to Promote Macrophage Efferocytosis and Repolarization for Atherosclerosis Therapy.
    Tang C; Wang H; Guo L; Zou C; Hu J; Zhang H; Zhou W; Yang G
    ACS Appl Mater Interfaces; 2023 Nov; ():. PubMed ID: 37910772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dual-Function CD47-Targeting Nano-Drug Delivery System Used to Regulate Immune and Anti-Inflammatory Activities in the Treatment of Atherosclerosis.
    Wang H; Zhao R; Peng L; Yu A; Wang Y
    Adv Healthc Mater; 2024 Sep; 13(22):e2400752. PubMed ID: 38794825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis.
    Wang Y; Zhao C; Liu Y; Wang C; Jiang H; Hu Y; Wu J
    Mol Pharm; 2022 May; 19(5):1273-1293. PubMed ID: 35436123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD47-Mediated Hedgehog/SMO/GLI1 Signaling Promotes Mesenchymal Stem Cell Immunomodulation in Mouse Liver Inflammation.
    Sheng M; Lin Y; Xu D; Tian Y; Zhan Y; Li C; Farmer DG; Kupiec-Weglinski JW; Ke B
    Hepatology; 2021 Sep; 74(3):1560-1577. PubMed ID: 33765345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages regulate plaque progression in diabetic Apoe
    Liu WX; Hu YF; Tai GJ; Li YP; Li JP; Qiu S; Zheng RF; Damdinjav D; Otieno JN; Li XX; Xu M
    Atherosclerosis; 2024 Oct; 397():118556. PubMed ID: 39222595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD47- and Integrin α4/β1-Comodified-Macrophage-Membrane-Coated Nanoparticles Enable Delivery of Colchicine to Atherosclerotic Plaque.
    Li Y; Che J; Chang L; Guo M; Bao X; Mu D; Sun X; Zhang X; Lu W; Xie J
    Adv Healthc Mater; 2022 Feb; 11(4):e2101788. PubMed ID: 34786845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet Membrane-Coated Nanocarriers Targeting Plaques to Deliver Anti-CD47 Antibody for Atherosclerotic Therapy.
    Chen L; Zhou Z; Hu C; Maitz MF; Yang L; Luo R; Wang Y
    Research (Wash D C); 2022; 2022():9845459. PubMed ID: 35118420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.